Cite

HARVARD Citation

    Buhl, R. et al. (2017). Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease. Respiratory medicine. pp. 58-66. [Online]. 
  
Back to record